A scoring model predicts hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with nucleos(t)ide analogs: real-world clinical practice-Reference-Cited by-同舟云学术

A scoring model predicts hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with nucleos(t)ide analogs: real-world clinical practice

Published:2017-09 Issue: Volume:62 Page:18-25
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Geng Mingfan,Li Yuxin,Gao Fangyuan,Sun Le,Yang Xue,Wang Rui,Chen Jialiang,Zhang Qun,Wan Gang,Wang Xianbo

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference36 articles.

1. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection;Bertoletti;Gut,2012

2. Immune tolerance split between hepatitis B virus precore and core proteins;Chen;J Virol,2005

3. P0661: Prediction of HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients treated with entecavir using ALT and platelet count: Results from a large european multi-center study;Chi;Journal of Hepatology,2015

4. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group;Chien;Hepatology,1999

5. A low serum gamma-glutamyltransferase level predicts a sustained virological response in patients with chronic hepatitis C genotype 1;Dogan;Gut Liver,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues;Annals of Hepatology;2024-01

2. The role of different viral biomarkers on the management of chronic hepatitis B;Clinical and Molecular Hepatology;2023-04-01

3. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus;International Journal of Antimicrobial Agents;2022-11

4. Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore;Liver International;2022-08-08

5. A Clinical scoring model to predict mortality in HIV/TB co-infected patients at end stage of AIDS in China: An observational cohort study;BioScience Trends;2019-04-30